Skip to main content
IC
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
5.86
+0.15 (2.63%)
May 12, 2025, 4:00 PM EDT

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 88.08M CAD in the quarter ending March 31, 2025, with 1.70% growth. This brings the company's revenue in the last twelve months to 372.78M, up 12.21% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
372.78M
Revenue Growth
+12.21%
P/S Ratio
1.56
Revenue / Employee
500.37K
Employees
745
Market Cap
582.77M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Green Thumb Industries 1.64B
dentalcorp Holdings 1.55B
Sienna Senior Living 896.45M
Extendicare 1.47B
Trulieve Cannabis 1.71B
Cronos Group 179.08M
WELL Health Technologies 919.69M
Curaleaf Holdings 1.89B
Revenue Rankings

Knight Therapeutics News

More News